BioGeometry secured $100M in Series A+ financing led by China Life Capital to advance its life science AI platforms GeoFlow and GeoCell.
PRIVATEOct 28, 2026
Amount Raised
$100 Million
Round Type
Series A
ChinaBiotechnologyArtificial Intelligence
Investors
Dacheng Wealth CapitalGuofang Venture CapitalReliance InvestmentChina Development Venture CapitalShanghai Biomedical Industry FundChina Life Capital
Description
BioGeometry, an AI-native biopharmaceutical company, completed its Series A+ financing round totaling $100M, led by China Life Capital with participation from multiple institutional investors. Existing shareholders including Shanghai Biomedical Industry Fund and Dacheng Wealth Capital increased their stakes in the round. The funding will support development of the company's molecular and cellular-level micro-world models (GeoFlow and GeoCell), expansion of high-throughput automated laboratories, and commercialization of its drug pipelines.
Who to call at BioGeometry, and when
A new round usually means BioGeometry is about to hire and buy. The teams that reach out first get the meeting.
An alert the day BioGeometry raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at BioGeometry, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioGeometry. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
BioGeometry
Location
China
About
BioGeometry is an AI Native biopharmaceutical company developing life science superintelligence through self-evolving microcosm models. The company has built GeoFlow and GeoCell, multi-scale micro-world models connecting molecular and cellular levels for drug discovery and development. Their technology integrates structure prediction, de novo design, and multi-step reasoning to accelerate the discovery of therapeutic molecules and understand disease biology.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioGeometry raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ChinaBiotechnologyArtificial Intelligence